Evidence map›Paper›PMID 25695744›Full record

ArticleCell cycle (Georgetown, Tex.)2015

LIF-JAK1-STAT3 signaling delays contact inhibition of human corneal endothelial cells.

Xin Liu, Scheffer C G Tseng, Ming-Chang Zhang, Szu-Yu Chen, Sean Tighe, Wen-Juan Lu, Ying-Ting Zhu

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. p120-Catenin suppresses NLRP3 inflammasome activation in macrophages.American journal of physiology. Lung cellular and molecular physiology · 2023
    Article
  6. Effects ofFrontiers in pharmacology · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Human Trabecular Meshwork Progenitors.International journal of medical sciences · 2019
    Review
  12. Review
  13. Article
  14. Article
  15. Cell-size distribution in epithelial tissue formation and homeostasis.Journal of the Royal Society, Interface · 2017
    Article
  16. Human Corneal Endothelial Cells ExpandedInternational journal of medical sciences · 2017
    Review
  17. Review
  18. Article
  19. Senescence Mediated by p16Scientific reports · 2016
    Article
  20. Engineering of Human Corneal Endothelial Grafts.Current ophthalmology reports · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Xin Liua Department of Ophthalmology; Union Hospital; Tongji Medical College ; Huazhong University of Science and Technology ; Wuhan , China.
Scheffer C G Tseng
Ming-Chang Zhang
Szu-Yu Chen
Sean Tighe
Wen-Juan Lu
Ying-Ting Zhu
Huazhong University of Science and Technology · CNOcular Surface Center · USShanghai Jiao Tong University · CN

Funding

Engineering of Human Corneal Endothelial GraftsR44EY022502 · NEI · TISSUETECH, INC. · PI ZHU, YING TING · 2014 to 2015
$1.2M
Engineering of Human Corneal Endothelial GraftsR43EY022502 · NEI · TISSUETECH, INC. · PI ZHU, YING TING · 2012 to 2012
$211k
NEI NIH HHS R43 EY 022502-01NEI NIH HHS R44 EY022502NEI NIH HHS R44 EY 022502-02
6 · The paper itself

Abstract

Human corneal endothelial cells (HCECs) responsible for corneal transparency have limited proliferative capacity in vivo because of "contact-inhibition." This feature has hampered the ability to engineer HCECs for transplantation. Previously we have reported an in vitro model of HCECs in which contact inhibition was re-established at Day 21, even though cell junction and cell matrix interaction were not perturbed during isolation. Herein, we observe that such HCEC monolayers continue to expand and retain a normal phenotype for 2 more weeks if cultured in a leukemia inhibitory factor (LIF)-containing serum-free medium. Such expansion is accompanied initially by upregulation of Cyclin E2 colocalized with nuclear translocation of phosphorylated retinoblastoma tumor suppressor (p-Rb) at Day 21 followed by a delay in contact inhibition through activation of LIF-Janus kinase1 (JAK1)-signal transducer and activator of transcription 3 (STAT3) signaling at Day 35. The LIF-JAK1-STAT3 signaling is coupled with upregulation of E2F2 colocalized with nuclear p-Rb and with concomitant downregulation of p16(INK4a), of which upregulation is linked to senescence. Hence, activation of LIF-JAK1-STAT3 signaling to delay contact inhibition can be used as another strategy to facilitate engineering of HCEC grafts to solve the unmet global shortage of corneal grafts.

Indexed as

AdolescentAdultAgedCell NucleusCells, CulturedContact InhibitionCorneaCyclin-Dependent Kinase Inhibitor p16E2F2 Transcription FactorEndothelial CellsFibroblast Growth Factor 2HumansJanus Kinase 1Leukemia Inhibitory FactorMiddle AgedRetinoblastoma ProteinCyclin-Dependent Kinase Inhibitor p16E2F2 Transcription FactorFibroblast Growth Factor 2Janus Kinase 1Leukemia Inhibitory FactorRetinoblastoma ProteinRNA, Small InterferingSTAT3 Transcription FactorbFGF, basic fibroblast growth factorBMP, bone morphogenetic proteinBrdU, bromodeoxyuridineCDK, cyclin-dependent kinaseCKI, cyclin-dependent kinase inhibitorscontact inhibitioncorneal endotheliumDMEM, Dulbecco's modified Eagle's mediumE2F2EDTA, ethylenediaminetetraacetic acidEGF, epidermal growth factorEMT, endothelial mesenchymal transitionESC, embryonic stem cellFBS, fetal bovine serumGAPDH, glyceraldehyde-3- phosphate dehydrogenaseHBSS, Hanks’ balanced salt solutionHCEC, human corneal endothelial cellID, inhibitor of differentiationiPSCs, induced pluripotent stem cellsITS, insulin-transferrin-sodium seleniteJAK1JAK, Janus kinaseLEF1, lymphoid enhancer-binding factor 1LIFLIF, leukemia inhibitory factorMESCM, modified embryonic stem cell mediumNC, neural crestNFkB, nuclear factor kappa-light-chain-enhancer of activated B cellsp120, p120 cateninp16INK4aPBS, phosphate-buffered salineproliferationRb, retinoblastoma tumor suppressorRPE, retinal pigment epithelial cellsscRNA, scramble RNASHEM, supplemental hormonal epithelial mediumsiRNA, small interfering ribonucleic acidSTAT3STAT3, signal transducer and activator of transcription 3ZO-1, Zona occludens protein 1

Identifiers

PMID25695744
PMCPMC4613548
OpenAlexW1854656747

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.